PubRank

Göran K Hansson

Author PubWeight™ 126.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Progress and challenges in translating the biology of atherosclerosis. Nature 2011 9.41
2 Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009 6.11
3 Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006 4.28
4 Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002 3.60
5 Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002 2.58
6 Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003 2.44
7 Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013 2.37
8 T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 2006 2.12
9 Adaptive immunity and atherosclerosis. Clin Immunol 2009 2.08
10 Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 2003 1.98
11 Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 2003 1.95
12 Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 2007 1.94
13 T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice. Circ Res 2009 1.93
14 Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet 2010 1.86
15 Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2005 1.85
16 Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002 1.82
17 CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 2004 1.80
18 Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts. Circulation 2011 1.78
19 Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ Res 2005 1.67
20 CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 2008 1.64
21 Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest 2013 1.61
22 Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions. Cardiovasc Res 2009 1.57
23 Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004 1.54
24 Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med 2010 1.52
25 Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol 2006 1.47
26 Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc Natl Acad Sci U S A 2005 1.41
27 Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 2009 1.36
28 Accumulation of foam cells in liver X receptor-deficient mice. Circulation 2002 1.34
29 Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 2011 1.33
30 Innate immune signals in atherosclerosis. Clin Immunol 2009 1.32
31 Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2010 1.31
32 Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A 2006 1.28
33 Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis. Arterioscler Thromb Vasc Biol 2009 1.25
34 Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol 2004 1.23
35 Effect of sex and age on serum biochemical reference ranges in C57BL/6J mice. Comp Med 2004 1.23
36 Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells. J Biol Chem 2009 1.22
37 Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler Thromb Vasc Biol 2006 1.22
38 Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol 2006 1.21
39 CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004 1.21
40 Chemokines and atherosclerosis. Ann Med 2004 1.14
41 Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice. Arterioscler Thromb Vasc Biol 2004 1.12
42 5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ Res 2007 1.11
43 Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. J Mol Cell Cardiol 2007 1.08
44 Immunology of ischemic vascular disease: plaque to attack. Trends Immunol 2005 1.07
45 Leukotriene receptors in atherosclerosis. Ann Med 2006 1.07
46 Highlights of 10 years of immunology in Nature Reviews Immunology. Nat Rev Immunol 2011 1.06
47 IKKbeta-dependent NF-kappaB pathway controls vascular inflammation and intimal hyperplasia. FASEB J 2005 1.06
48 The use of network analyses for elucidating mechanisms in cardiovascular disease. Mol Biosyst 2009 1.06
49 Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med 2013 1.02
50 Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2007 1.02
51 T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. Am J Pathol 2009 1.01
52 Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation. Circulation 2012 0.99
53 Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int J Mol Med 2005 0.95
54 12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis 2011 0.95
55 Vaccination against atherosclerosis: science or fiction? Circulation 2002 0.93
56 Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice. Atherosclerosis 2009 0.92
57 Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice--brief report. Arterioscler Thromb Vasc Biol 2009 0.92
58 Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ Cardiovasc Genet 2012 0.92
59 Toll to be paid at the gateway to the vessel wall. Arterioscler Thromb Vasc Biol 2005 0.91
60 CARD8 gene encoding a protein of innate immunity is expressed in human atherosclerosis and associated with markers of inflammation. Clin Sci (Lond) 2013 0.91
61 Platelets regulate CD4⁺ T-cell differentiation via multiple chemokines in humans. Thromb Haemost 2011 0.90
62 Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. Cardiovasc Res 2013 0.88
63 HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. Atherosclerosis 2003 0.88
64 Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation 2011 0.88
65 Lack of invariant natural killer T cells affects lipid metabolism in adipose tissue of diet-induced obese mice. Arterioscler Thromb Vasc Biol 2013 0.87
66 Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice. Atherosclerosis 2008 0.87
67 Prediction of ischemic events on the basis of transcriptomic and genomic profiling in patients undergoing carotid endarterectomy. Mol Med 2012 0.87
68 Valvular osteoclasts in calcification and aortic valve stenosis severity. Int J Cardiol 2013 0.85
69 NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis. Arterioscler Thromb Vasc Biol 2013 0.84
70 Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe⁻/⁻ mice. Immunobiology 2011 0.84
71 Rip2 deficiency leads to increased atherosclerosis despite decreased inflammation. Circ Res 2011 0.84
72 Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion. J Mol Med (Berl) 2010 0.84
73 Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis. Circ Res 2008 0.83
74 The tryptophan metabolite 3-hydroxyanthranilic acid lowers plasma lipids and decreases atherosclerosis in hypercholesterolaemic mice. Eur Heart J 2012 0.83
75 Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice. Eur J Immunol 2014 0.82
76 The atheroprotective effect of 17beta-estradiol depends on complex interactions in adaptive immunity. Am J Pathol 2005 0.82
77 Two views on plaque rupture. Arterioscler Thromb Vasc Biol 2007 0.81
78 Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease. PLoS One 2012 0.81
79 Deficiency of nitric oxide synthase 2 results in increased neointima formation in a mouse model of vascular injury. J Cardiovasc Pharmacol 2003 0.81
80 Modulation of autoimmunity and atherosclerosis - common targets and promising translational approaches against disease. Circ J 2015 0.79
81 Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization. Atherosclerosis 2012 0.79
82 Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions. Atherosclerosis 2006 0.78
83 Gene deletion of NF-kappaB p105 enhances neointima formation in a mouse model of carotid artery injury. Cardiovasc Drugs Ther 2006 0.78
84 The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis. Thromb Haemost 2009 0.78
85 Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) mice. J Cell Mol Med 2013 0.77
86 T cell-based therapies for atherosclerosis. Curr Pharm Des 2013 0.77
87 CDR3 sequence preference of TCRBV8S2+ T cells within the CNS does not reflect single amino acid dependent avidity expansion. J Neuroimmunol 2005 0.77
88 Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice. Am J Physiol Heart Circ Physiol 2004 0.76
89 The B cell: a good guy in vascular disease? Arterioscler Thromb Vasc Biol 2002 0.76
90 Immunomodulation and vaccination for atherosclerosis. Expert Opin Biol Ther 2004 0.76
91 Epidemiology complements immunology in the heart. Arterioscler Thromb Vasc Biol 2006 0.75
92 Glimpse of the secret life of the plaque. Arterioscler Thromb Vasc Biol 2004 0.75
93 TGF-beta in atherosclerosis. Arterioscler Thromb Vasc Biol 2004 0.75
94 Dr Jérémy Fauconnier talks with Prof Göran K. Hansson. Cardiovasc Res 2017 0.75
95 ATVB in focus: Smooth muscle cells. Arterioscler Thromb Vasc Biol 2003 0.75
96 Activation of VPAC1 receptors aggravates early atherosclerosis in hypercholesterolemic apolipoprotein E-deficient mice. Biochem Biophys Res Commun 2010 0.75
97 Vaccination and atherosclerosis. Curr Atheroscler Rep 2004 0.75
98 Letter to the Editor: Autoreactive CD4+CD28- T Cells and Acute Coronary Syndromes. Arterioscler Thromb Vasc Biol 2007 0.75